Crinetics Pharmaceuticals, Inc. (CRNX)

Crinetics Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 16, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,740	4,742	2,377	985	1,340	465
Market Cap Growth	21.05%	99.50%	141.36%	-26.50%	188.40%	-23.56%
Enterprise Value	4,696	3,932	1,874	620	1,151	283
Last Close Price	55.99	51.13	35.58	18.30	28.41	14.11
PS Ratio	3739.18	4563.69	592.26	207.88	1242.80	6542.73
PB Ratio	4.94	3.58	4.41	3.11	4.04	2.75
P/TBV Ratio	5.35	3.58	4.41	3.11	4.04	2.75
EV/Sales Ratio	3059.60	3783.97	467.04	130.82	1067.39	3982.45
Debt / Equity Ratio	0.05	0.04	0.10	0.01	0.01	0.03
Asset Turnover	0.00	0.00	0.01	0.01	0.00	0
Quick Ratio	14.73	22.83	12.92	12.17	20.96	16.47
Current Ratio	15.12	23.05	13.07	12.45	21.55	16.92
Return on Equity (ROE)	-44.42%	-32.02%	-50.16%	-50.57%	-42.98%	-51.61%
Return on Assets (ROA)	-28.00%	-20.46%	-28.18%	-29.84%	-25.19%	-29.85%
Return on Invested Capital (ROIC)	-29.76%	-21.53%	-30.57%	-32.02%	-26.41%	-31.60%
Return on Capital Employed (ROCE)	-42.60%	-24.60%	-37.60%	-51.70%	-32.10%	-43.30%
Earnings Yield	-7.37%	-6.29%	-9.03%	-16.65%	-8.04%	-15.89%
FCF Yield	-6.17%	-4.85%	-7.20%	-11.87%	-6.64%	-13.39%
Buyback Yield / Dilution	-24.75%	-39.11%	-11.71%	-35.24%	-26.24%	-25.95%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q